Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Anthony Q. Pham, Stephen M. Broski, Thomas M. Habermann, Dragan Jevremovic, Gregory A. Wiseman, Andrew L. Feldman, Matthew J. Maurer, Kay M. Ristow & Thomas E. Witzig. (2017) Accuracy of 18-F FDG PET/CT to detect bone marrow clearance in patients with peripheral T-cell lymphoma – tissue remains the issue. Leukemia & Lymphoma 58:10, pages 2342-2348.
Read now
Read now
Tarec Christoffer El-Galaly, Martin Hutchings, Karen Juul Mylam, Peter de Nully Brown, Anne Bukh, Hans Erik Johnsen, Peter Kamper, Annika Loft, Victor Iyer, Lars Christian Gormsen, Anne Lerberg Nielsen, Martin Bøgsted & Francesco d’Amore. (2014) Impact of 18F-fluorodeoxyglucose positron emission tomography/computed tomography staging in newly diagnosed classical Hodgkin lymphoma: fewer cases with stage I disease and more with skeletal involvement. Leukemia & Lymphoma 55:10, pages 2349-2355.
Read now
Read now
Róisín Hamilton, Iain Andrews, Pamela McKay & Mike Leach. (2014) Loss of utility of bone marrow biopsy as a staging evaluation for Hodgkin lymphoma in the positron emission tomography–computed tomography era: a West of Scotland study. Leukemia & Lymphoma 55:5, pages 1049-1052.
Read now
Read now
Martin Hutchings. (2012) The role of bone marrow biopsy in Hodgkin lymphoma staging: “To be, or not to be, that is the question”?. Leukemia & Lymphoma 53:4, pages 523-524.
Read now
Read now
Michael S. Hofman. (2012) Fluorodeoxyglucose positron emission tomography/computed tomography for evaluation of bone marrow involvement in lymphoma: when is it superior to biopsy?. Leukemia & Lymphoma 53:3, pages 349-351.
Read now
Read now
Articles from other publishers (30)
Akram Al-Ibraheem, Felix M Mottaghy & Malik E. Juweid. (2023) PET/CT in Hodgkin Lymphoma: An Update. Seminars in Nuclear Medicine 53:3, pages 303-319.
Crossref
Crossref
Ananth Shankar, Georgina W. Hall, Pam McKay, Eve Gallop‐Evans, Patrick Fielding & Graham P. Collins. (2022)
Management of children and adults with all stages of nodular lymphocyte predominant Hodgkin lymphoma — All
St
AGE
s
: A consensus‐based position paper from the Hodgkin lymphoma subgroup of the
UK
National Cancer Research Institute
. British Journal of Haematology 197:6, pages 679-690.
Crossref
Crossref
Malik E. Juweid, Marguerite Mueller, Abdullah Alhouri, M. Ziad A‐Risheq & Felix M. Mottaghy. (2021) Positron emission tomography/computed tomography in the management of Hodgkin and B‐cell non‐Hodgkin lymphoma: An update. Cancer 127:20, pages 3727-3741.
Crossref
Crossref
Xianwen Hu, Dandan Li, Guomei Hu, Qi Huang, Pan Wang & Jiong Cai. (2021) Diagnostic performance of 18F-FDG PET/CT in pediatric lymphoma infiltrating bone marrow: a meta-analysis. Clinical and Translational Imaging 9:5, pages 511-522.
Crossref
Crossref
Steven H. KroftCordelia E. SeverAdam BaggBrooke Billman, Catherine DiefenbachDavid M. DorfmanWilliam G. FinnDita A. GratzingerPatricia A. GreggJohn P. LeonardSonali SmithLesley Souter, Ronald L. WeissChristina B. Ventura & Matthew C. Cheung. (2021) Laboratory Workup of Lymphoma in Adults: Guideline From the American Society for Clinical Pathology and the College of American Pathologists. Archives of Pathology & Laboratory Medicine 145:3, pages 269-290.
Crossref
Crossref
Steven H Kroft, Cordelia E Sever, Adam Bagg, Brooke Billman, Catherine Diefenbach, David M Dorfman, William G Finn, Dita A Gratzinger, Patricia A Gregg, John P Leonard, Sonali Smith, Lesley Souter, Ronald L Weiss, Christina B Ventura & Matthew C Cheung. (2021) Laboratory Workup of Lymphoma in Adults. American Journal of Clinical Pathology 155:1, pages 12-37.
Crossref
Crossref
Ji-cheng Zhou, Mei-qing Wu, Zheng-mian Peng, Wei-hua Zhao & Zhen-jie Bai. (2020) Clinical analysis of 20 patients with non-Hodgkin lymphoma and autoimmune hemolytic anemia. Medicine 99:7, pages e19015.
Crossref
Crossref
William Y. Raynor, Mahdi Zirakchian Zadeh, Esha Kothekar, Dani P. Yellanki & Abass Alavi. (2019) Evolving Role of PET-Based Novel Quantitative Techniques in the Management of Hematological Malignancies. PET Clinics 14:3, pages 331-340.
Crossref
Crossref
Junichi Tsuchiya, Masahide Yamamoto, Hyeyeol Bae, Takumi Oshima, Tomohiro Yoneyama, Osamu Miura & Ukihide Tateishi. (2019) Tumor Identification of Less Aggressive or Indolent Lymphoma With Whole-Body 11C-Acetate PET/CT. Clinical Nuclear Medicine 44:4, pages 276-281.
Crossref
Crossref
C. Bodet-Milin, E. Itti & P.Y. Salaün. (2019) Lymphomes. Médecine Nucléaire 43:1, pages 150-160.
Crossref
Crossref
Juliano Júlio Cerci, Mateos Bogoni, Valeria Buccheri, Elba Cristina Sá de Camargo Etchebehere, Talita Maira Bueno da Silveira, Otavio Baiocchi, Carlos de Araujo Cunha Pereira Neto, Marcelo Tatit Sapienza, Jose Flavio Gomes Marin, José Cláudio Meneghetti, Yana Novis, Carmino Antonio de Souza, Carlos Chiattone, Marcia Torresan & Celso Dario Ramos. (2018) Fluorodeoxyglucose-positron emission tomography staging can replace bone marrow biopsy in Hodgkin's lymphoma. Results from Brazilian Hodgkin's Lymphoma Study Group. Hematology, Transfusion and Cell Therapy 40:3, pages 245-249.
Crossref
Crossref
Angelina Cistaro, Laura Cassalia, Cinzia Ferrara, Natale Quartuccio, Laura Evangelista, Maurizio Bianchi, Franca Fagioli, Gianni Bisi, Sergio Baldari, Alessandro Zanella, Marta Pillon, Pietro Zucchetta, Marta Burei, Alessandra Sala, Luca Guerra, Priscilla Guglielmo, Roberta Burnelli, Stefano Panareo, Federica Scalorbi, Ilaria Rambaldi, Arnoldo Piccardo, Alberto Garaventa, Demetrio Familiari, Maria Concetta Fornito, Egesta Lopci, Maurizio Mascarin, Corinna Altini, Cristina Ferrari, Teresa Perillo, Nicola Santoro, Eugenio Borsatti & Giuseppe Rubini. (2018) Italian Multicenter Study on Accuracy of 18 F-FDG PET/CT in Assessing Bone Marrow Involvement in Pediatric Hodgkin Lymphoma. Clinical Lymphoma Myeloma and Leukemia 18:6, pages e267-e273.
Crossref
Crossref
S. Sasse, P. J. Bröckelmann, C. Baues, H. T. Eich & A. Engert. (2018) Therapie des Hodgkin-Lymphoms in frühen und intermediären StadienTreatment of early stage Hodgkin lymphoma. Der Onkologe 24:4, pages 303-314.
Crossref
Crossref
Tarec Christoffer El-Galaly, Lars Christian Gormsen & Martin Hutchings. (2018) PET/CT for Staging; Past, Present, and Future. Seminars in Nuclear Medicine 48:1, pages 4-16.
Crossref
Crossref
P. Tamayo, A. Martín, L. Díaz, M. Cabrero, R. García, P. García-Talavera & D. Caballero. (2017) 18 F-FDG PET/CT in the clinical management of patients with lymphoma. Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) 36:5, pages 312-321.
Crossref
Crossref
P. Tamayo, A. Martín, L. Díaz, M. Cabrero, R. García, P. García-Talavera & D. Caballero. (2017) 18 F-FDG PET/TC en el manejo clínico de los linfomas. Revista Española de Medicina Nuclear e Imagen Molecular 36:5, pages 312-321.
Crossref
Crossref
L. Valls, C. Badve, S. Avril, K. Herrmann, P. Faulhaber, J. O'Donnell & N. Avril. (2016) FDG-PET imaging in hematological malignancies. Blood Reviews 30:4, pages 317-331.
Crossref
Crossref
Hugo J.A. Adams, Rutger A.J. Nievelstein & Thomas C. Kwee. (2015) Opportunities and limitations of bone marrow biopsy and bone marrow FDG-PET in lymphoma. Blood Reviews 29:6, pages 417-425.
Crossref
Crossref
Sarah A. Johnson, Anita Kumar, Matthew J. Matasar, Heiko Schöder & Jürgen Rademaker. (2015) Imaging for Staging and Response Assessment in Lymphoma. Radiology 276:2, pages 323-338.
Crossref
Crossref
Sally F. BarringtonN. George MikhaeelLale KostakogluMichel MeignanMartin HutchingsStefan P. MüellerLawrence H. SchwartzEmanuele ZuccaRichard I. FisherJudith TrotmanOtto S. HoekstraRodney J. HicksMichael J. O'DohertyRoland HustinxAlberto BiggiBruce D. Cheson. (2014) Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group. Journal of Clinical Oncology 32:27, pages 3048-3058.
Crossref
Crossref
H.J.A. Adams, T.C. Kwee, B. de Keizer, R. Fijnheer, J.M.H. de Klerk, A.S. Littooij & R.A.J. Nievelstein. (2014) Systematic review and meta-analysis on the diagnostic performance of FDG-PET/CT in detecting bone marrow involvement in newly diagnosed Hodgkin lymphoma: is bone marrow biopsy still necessary?. Annals of Oncology 25:5, pages 921-927.
Crossref
Crossref
M. Dietlein, G. Kuhnert, R. Semrau, B. Nast-Kolb, C. Baues, M. Fuchs, A. Drzezga & C. Kobe. (2014) Aktueller Stellenwert der Positronenemissionstomographie beim Hodgkin-LymphomCurrent importance of positron emission tomography in Hodgkin’s lymphoma. Der Onkologe 20:5, pages 429-440.
Crossref
Crossref
Lale Kostakoglu & Bruce D. Cheson. (2014) Current role of FDG PET/CT in lymphoma. European Journal of Nuclear Medicine and Molecular Imaging 41:5, pages 1004-1027.
Crossref
Crossref
Inas El-Najjar, Silvia Montoto, Amy McDowell, Janet Matthews, John Gribben & Teresa A. Szyszko. (2014) The value of semiquantitative analysis in identifying diffuse bone marrow involvement in follicular lymphoma. Nuclear Medicine Communications 35:3, pages 311-315.
Crossref
Crossref
Michael Lin & Divesh Kumar. 2014. Functional Imaging in Oncology. Functional Imaging in Oncology
181
211
.
Frederick D. Grant. 2014. Pediatric Nuclear Medicine and Molecular Imaging. Pediatric Nuclear Medicine and Molecular Imaging
479
496
.
Ukihide Tateishi. (2013) PET/CT in malignant lymphoma: basic information, clinical application, and proposal. International Journal of Hematology 98:4, pages 398-405.
Crossref
Crossref
S. N. Reske & T. Kull. (2013) Indikationen der modernen PET/CT-Diagnostik. best practice onkologie 8:3, pages 44-49.
Crossref
Crossref
Gang Cheng & Abass Alavi. (2013) Value of 18F-FDG PET versus iliac biopsy in the initial evaluation of bone marrow infiltration in the case of Hodgkin’s disease. Nuclear Medicine Communications 34:1, pages 25-31.
Crossref
Crossref
Tarec Christoffer El-GalalyFrancesco d'AmoreKaren Juul MylamPeter de Nully BrownMartin BøgstedAnne BukhLena SpechtAnnika LoftVictor IyerKarin HjorthaugAnne Lerberg NielsenIlse ChristiansenCharlotte MadsenHans-Erik JohnsenMartin Hutchings. (2012) Routine Bone Marrow Biopsy Has Little or No Therapeutic Consequence for Positron Emission Tomography/Computed Tomography–Staged Treatment-Naive Patients With Hodgkin Lymphoma. Journal of Clinical Oncology 30:36, pages 4508-4514.
Crossref
Crossref